Discovery and characterization of potent broadly neutralizing antibodies from human survivors of severe fever with thrombocytopenia syndrome
The National Key Research and Development Plan of China (2018YFE0200401, 2022YFC2303300), National Natural Science Foundation of China (81825019), China Postdoctoral Science Foundation (2023M741824).
Authors
- Yu Leng (ORCID: https://orcid.org/0000-0002-0485-6960)
- Jiachen Li (ORCID: https://orcid.org/0000-0002-3543-6088)
- Yu Guo (ORCID: https://orcid.org/0000-0002-8109-7515)
- Xue‐Fang Peng (ORCID: https://orcid.org/0000-0002-4817-3117)
- Shuo Han (ORCID: https://orcid.org/0000-0002-2222-0712)
- Yong‐Xiang Wu (ORCID: https://orcid.org/0000-0002-0862-2432)
- Lingjie Xu (ORCID: https://orcid.org/0000-0003-4330-1535)
- Hao Li (ORCID: https://orcid.org/0000-0002-6280-267X)
- Wei Liu (ORCID: https://orcid.org/0000-0002-9302-8170)
- Shuo Zhang (ORCID: https://orcid.org/0000-0001-8171-2779)
- Fei Wang (ORCID: https://orcid.org/0000-0001-9459-9461)
- Hongkai Zhang (ORCID: https://orcid.org/0000-0003-2186-5508)
- Xiaoyu Xu (ORCID: https://orcid.org/0000-0001-6958-6597)
- Xin Yang (ORCID: https://orcid.org/0000-0002-7343-8412)
- Ning Cui (ORCID: https://orcid.org/0000-0003-2505-098X)
- Hang Shang (ORCID: https://orcid.org/0009-0003-0420-5273)
- Nan Zhang
Institutions
- Novozymes (Denmark) (DK)
- Nankai University (CN)
- Southwest Forestry University (CN)
- Academy of Military Medical Sciences (CN)
- Xinyang Central Hospital (CN)
- Viva Biotech (China) (CN)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105481
- Citations
- 14
- Primary Topic
- Viral Infections and Vectors
- Type
- article
- Field-Weighted Citation Impact
- 5.45
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation